These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 423182)

  • 21. Changes of activity of daunorubicin, adriamycin and stereoisomers following the introduction or removal of hydroxyl groups in the amino sugar moiety.
    Di Marco A; Casazza AM; Dasdia T; Necco A; Pratesi G; Rivolta P; Velcich A; Zaccara A; Zunino F
    Chem Biol Interact; 1977 Dec; 19(3):291-302. PubMed ID: 597963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl ether, and adriamycin.
    DuVernay VH; Pachter JA; Crooke ST
    Cancer Res; 1980 Feb; 40(2):387-94. PubMed ID: 7356521
    [No Abstract]   [Full Text] [Related]  

  • 23. Antitumor effect of selected daunorubicin derivatives in mice with P 388 leukemia.
    Kuśnierczyk H; Rak J; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):259-62. PubMed ID: 3592929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antileukemic activity of synthetic daunomycinone derivatives bearing modifications in the glycosidic moiety.
    Perchellet EM; Sperfslage BJ; McIlvain CJ; Aligiannis N; Pouli N; Marakos P; Skaltsounis AL; Perchellet JP
    Anticancer Res; 2001; 21(6A):3957-67. PubMed ID: 11911277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor septacidin analogues.
    Acton EM; Ryan KJ; Luetzow AE
    J Med Chem; 1977 Nov; 20(11):1362-71. PubMed ID: 915894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. o-Methylation on anthracyclines and anthracyclinones. New o-methyl ethers of daunorubicin and its analogues.
    Cassinelli G; Di Matteo F; Forenza S; Ripamonti MC; Ruggieri D; Vigevani A; Arcamone F
    Farmaco Sci; 1982 Aug; 37(8):501-13. PubMed ID: 6957317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antitumor activity of 3'-C-methyl-daunorubicin.
    Thang TT; Imbach JL; Fizames C; Lavelle F; Ponsinet G; Olesker A; Lukacs G
    Carbohydr Res; 1985 Jan; 135(2):241-7. PubMed ID: 3986844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of various substitutions in positions 1, 2, 3, and 4 of 4-demethoxydaunorubicin and 4-demethoxyadriamycin.
    Di Marco A; Casazza AM; Soranzo C; Pratesi G
    Cancer Chemother Pharmacol; 1978; 1(4):249-54. PubMed ID: 750112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3'-deamino-3'-morpholino derivatives of daunomycin, adriamycin and carminomycin.
    Takahashi Y; Kinoshita M; Masuda T; Tatsuta K; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1982 Jan; 35(1):117-8. PubMed ID: 7068512
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative biochemical studies of adriamycin and daunomycin in leukemic cells.
    Wang JJ; Chervinsky DS; Rosen JM
    Cancer Res; 1972 Mar; 32(3):511-5. PubMed ID: 5061305
    [No Abstract]   [Full Text] [Related]  

  • 31. 7-(Aminoethyl) ether and thioether of daunomycinone.
    Acton EM; Tong GL; Mosher CW; Smith TH; Henry DW
    J Med Chem; 1979 Aug; 22(8):922-6. PubMed ID: 490537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological properties of oxazolinodaunorubicin--a new derivative of daunorubicin with a modified daunosamine moiety.
    Lukawska M; Wietrzyk J; Opolski A; Oszczapowicz J; Oszczapowicz I
    Invest New Drugs; 2010 Oct; 28(5):600-8. PubMed ID: 19711013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adriamycin analogs hydroxylated at c-3': synthesis and antitumor activity.
    Horton D; Turner WR
    Carbohydr Res; 1979 Dec; 77():C8-C11. PubMed ID: 519652
    [No Abstract]   [Full Text] [Related]  

  • 34. [Models of preclinical studies of anthracyclines].
    Fizames C
    Pathol Biol (Paris); 1987 Jan; 35(1):41-8. PubMed ID: 3550611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and antitumor activity of 7-O-[2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)-alpha-L-talopyranosyl]- daunomycinone and -adriamycinone.
    Nakai K; Takagi Y; Tsuchiya T
    Carbohydr Res; 1999 Mar; 316(1-4):47-57. PubMed ID: 10420587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New daunorubicin analogs. 3-Amino-2,3,6-trideoxy-alpha- and beta-D-arabino- and 3,6-diamino-2,3,6-trideoxy- alpha-D-ribo-hexopyranosides of daunomycinone.
    Fuchs EF; Horton D; Weckerle W; Winter B
    J Antibiot (Tokyo); 1979 Mar; 32(3):223-38. PubMed ID: 457582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-tumor activity of daunorubicin linked to poly-L-aspartic acid.
    Zunino F; Giuliani F; Savi G; Dasdia T; Gambetta R
    Int J Cancer; 1982 Oct; 30(4):465-70. PubMed ID: 7141741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological activity of the two isomeric 2'-C-methyl daunomycins.
    Rocherolle V; Olesker A; Lukacs G
    J Antibiot (Tokyo); 1989 Sep; 42(9):1393-7. PubMed ID: 2793594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new series of reductive amination derivatives of daunorubicin: syntheses, partition coefficients, and DNA binding.
    Yen SF; Wilson WD; Pearce SW; Gabbay EJ
    J Pharm Sci; 1984 Nov; 73(11):1575-9. PubMed ID: 6394744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cytostatic action of N-ethyl-13-dihydrorubomycin on the cells of various tumor strains].
    Volkolupova OP
    Antibiotiki; 1984 Jun; 29(6):435-7. PubMed ID: 6548103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.